Tango Therapeutics director awarded stock and options
Tango Therapeutics director Lee Sung received new equity awards consisting of restricted stock units and stock options.
Rhea-AI Filing Summary
Tango Therapeutics director Lee Sung received new equity awards consisting of restricted stock units and stock options. The filing shows a grant of 570 RSUs, each representing one share of common stock, increasing her direct common stock holdings to 22,870 shares after the award.
An additional stock option covering 3,570 shares of common stock was granted with an exercise price of $20.22 per share and an expiration date of June 5, 2036. The RSUs vest in full on the earlier of June 5, 2027 or the next annual stockholder meeting, while the option vests in 12 equal monthly installments starting July 5, 2026, in each case contingent on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 4,140 shares
Grant/Award
2 txns
Insider
Lee Sung
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 3,570 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 570 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,570 contracts (Direct);
Common Stock — 22,870 shares (Direct)
Footnotes (2)
- F1. These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- F2. This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Key Figures
RSU grant size: 570 RSUs
Shares held after RSU grant: 22,870 shares
Stock option grant size: 3,570 options
+4 more
7 metrics
RSU grant size
570 RSUs
Each RSU represents one share of common stock
Shares held after RSU grant
22,870 shares
Director’s direct common stock holdings following award
Stock option grant size
3,570 options
Options to acquire common stock granted on June 5, 2026
Option exercise price
$20.22 per share
Strike price for the 3,570-share option award
Option expiration
June 5, 2036
Expiration date of the granted stock option
RSU vesting date
Earlier of June 5, 2027 or next annual meeting
RSUs vest in full at the earlier of these dates
Option vesting start
July 5, 2026
First of 12 monthly vesting installments for option
Key Terms
restricted stock units, RSUs, Stock Option (Right to Buy), vest, +2 more
6 terms
restricted stock units financial
"These shares are represented by restricted stock units (the "RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents a contingent right to receive one share of Common Stock"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
vest financial
"The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price: "20.2200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-05T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did Tango Therapeutics (TNGX) director Lee Sung receive in this Form 4?
Director Lee Sung received equity-based compensation from Tango Therapeutics, including 570 restricted stock units and a stock option for 3,570 shares. These awards are part of her director compensation and are subject to future vesting conditions tied to continued service.
What are the terms of Lee Sung’s new stock options at Tango Therapeutics (TNGX)?
Lee Sung received a stock option for 3,570 Tango Therapeutics shares with a $20.22 exercise price and a June 5, 2036 expiration date. The option vests in 12 substantially equal monthly installments starting July 5, 2026, conditional on her continued service.
When do Lee Sung’s restricted stock units from Tango Therapeutics (TNGX) vest?
The 570 restricted stock units vest in full on the earlier of June 5, 2027 or the date of the next annual stockholder meeting. Vesting requires Lee Sung to remain in continuous service with Tango Therapeutics through the applicable vesting date specified in the award terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
